Recombinant Human IRS2 Protein，His

IRS2 (Insulin Receptor Substrate 2) is a pivotal protein in the insulin signaling pathway, playing a crucial role in glucose homeostasis and energy metabolism. As a key adapter protein, IRS2 facilitates the transmission of signals from the insulin receptor to downstream pathways, including the PI3K/Akt pathway, which is integral for metabolic functions. Dysregulation of IRS2 has been linked to various metabolic disorders, including type 2 diabetes and obesity, highlighting its potential as a therapeutic target. Recent studies have shown that IRS2 is not only involved in insulin signaling but also has implications in cellular processes such as growth and differentiation. Researchers have been focusing on the recombinant expression of IRS2 to better understand its structural and functional characteristics. By producing IRS2 in a heterologous system, scientists can conduct in-depth functional assays and binding studies, unraveling its interactions with insulin receptors and other signaling molecules. This research is crucial for developing new strategies to enhance insulin sensitivity and address insulin resistance. Understanding the comprehensive role of IRS2 in metabolic pathways will contribute to devising novel interventions for metabolic diseases, underscoring the importance of ongoing studies of this protein.